SCHEMBL12686993

SCHEMBL12686993

CCC1C[C@@H](C(=O)OC)N(C(=O)OC(C)(C)C)C1=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.35
NR1H2 P55055 2/20 0.34
BRD4 O60885 1/20 0.34
MMP2 P08253 1/20 0.34
ANPEP P15144 1/20 0.34
NR1H3 Q13133 1/20 0.34
CETP P11597 1/20 0.34
CHRM2 P08172 1/20 0.33
CHRM1 P11229 1/20 0.33
CHRM3 P20309 1/20 0.33
PDE4B Q07343 1/20 0.33
KLK7 P49862 1/20 0.33
CYP3A4 P08684 2/20 0.33
MAPT P10636 2/20 0.33
FKBP1A P62942 1/20 0.33
TPSAB1 Q15661 1/20 0.32
TPSD1 Q9BZJ3 1/20 0.32
TPSG1 Q9NRR2 1/20 0.32
DDB1 Q16531 1/20 0.32
CRBN Q96SW2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6480393 1.00 PTPN1 (0.35) PTPN1NR1H2BRD4MMP2ANPEP
SCHEMBL19566179 0.92 NR1H2 (0.35) NR1H2CHRM2CHRM1CHRM3KLK7
SCHEMBL6494880 0.86 KLK7 (0.36) NR1H2CHRM2CHRM1CHRM3KLK7
SCHEMBL15659293 0.86 NR1H2 (0.37) PTPN1NR1H2MMP2ANPEPNR1H3
SCHEMBL15659291 0.86 NR1H2 (0.37) PTPN1NR1H2MMP2ANPEPNR1H3
SCHEMBL18256386 0.86 NR1H2 (0.37) PTPN1NR1H2MMP2ANPEPNR1H3
SCHEMBL25842893 0.86 PTPN1 (0.34) PTPN1NR1H2MMP2ANPEPNR1H3
Hydrochloric Acid SCHEMBL30661150 0.85 PTPN1 (0.33) PTPN1NR1H2MMP2ANPEPNR1H3
SCHEMBL6184927 0.85 FAAH (0.34) PTPN1NR1H2MMP2ANPEPNR1H3
SCHEMBL15700777 0.85 FAAH (0.34) PTPN1NR1H2MMP2ANPEPNR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012154777-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-11-15 WO disclosed
WO-2012109080-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-08-16 WO disclosed